Journal Logo

ASA-Randomized Controlled Trial: PDF Only

A Novel Immune Modulator for Patients With Necrotizing Soft Tissue Infections (NSTI)

Results of a Multicenter, Phase 3 Randomized Controlled Trial of Reltecimod (AB 103)

Bulger, Eileen M. MD*; May, Addison K. MD; Robinson, Bryce R. H. MD*; Evans, David C. MD; Henry, Sharon MD§; Green, John M. MD; Toschlog, Eric MD||; Sperry, Jason L. MD**; Fagenholz, Peter MD††; Martin, Niels D. MD‡‡; Dankner, Wayne M. MD§§; Maislin, Greg PhD¶¶; Wilfret, David MD§§; Bernard, Andrew C. MD|||| on behalf of the ACCUTE study Investigators

Author Information
doi: 10.1097/SLA.0000000000004102
  • Free
  • SDC
  • PAP


Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.